
NeuroOne Medical Tech (NASDAQ:NMTC) brought in sales totaling $33.75 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 6.22%, resulting in a loss of $2.81 million. NeuroOne Medical Tech collected $48.34 thousand in revenue during Q4, but reported earnings showed a $2.64 million loss.